HIV testing and its associated factors among street-based female sex workers in Iran: results of a national rapid assessment and response survey.
Drug use
Female sex workers
HIV testing
Iran
Journal
Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060
Informations de publication
Date de publication:
17 05 2021
17 05 2021
Historique:
accepted:
05
05
2021
entrez:
18
5
2021
pubmed:
19
5
2021
medline:
23
11
2021
Statut:
epublish
Résumé
Female sex workers (FSWs) are at a disproportionate risk of sexually transmitted infections and they may face significant barriers to HIV testing. This study aimed to examine HIV testing prevalence and its associated factors among street-based FSWs in Iran. A total of 898 FSWs were recruited from 414 venues across 19 major cities in Iran between October 2016 and March 2017. Eligible FSWs were women aged 18 years of age who had at least one commercial sexual intercourse in the previous year. HIV testing was defined as having tested for HIV in the lifetime. Bivariable and multivariable logistic regression were used to examine the correlates of HIV testing. We report adjusted odds ratios (aOR) and their 95% confidence intervals (CI). Overall, 57.8% (95%CI: 20.0, 88.0) of participants reported having tested for HIV, and HIV prevalence among FSWs who tested for HIV was 10.3% (95%CI: 7.5, 13.0). The multivariable model showed that unstable housing (aOR: 8.86, 95%CI: 2.68, 29.32) and drug use (aOR: 3.47, 95%CI: 1.33, 9.06) were associated with increased likelihood of HIV testing. However, FSWs with a higher level of income were less likely to be tested for HIV (aOR: 0.09, 95%CI: 0.02, 0.43). Almost one in ten street-based FSWs had never tested for HIV. These findings suggest the need for evidence-based strategies such as outreach support and HIV self-testing to improve HIV testing in this marginalized population.
Sections du résumé
BACKGROUND
Female sex workers (FSWs) are at a disproportionate risk of sexually transmitted infections and they may face significant barriers to HIV testing. This study aimed to examine HIV testing prevalence and its associated factors among street-based FSWs in Iran.
METHOD
A total of 898 FSWs were recruited from 414 venues across 19 major cities in Iran between October 2016 and March 2017. Eligible FSWs were women aged 18 years of age who had at least one commercial sexual intercourse in the previous year. HIV testing was defined as having tested for HIV in the lifetime. Bivariable and multivariable logistic regression were used to examine the correlates of HIV testing. We report adjusted odds ratios (aOR) and their 95% confidence intervals (CI).
RESULT
Overall, 57.8% (95%CI: 20.0, 88.0) of participants reported having tested for HIV, and HIV prevalence among FSWs who tested for HIV was 10.3% (95%CI: 7.5, 13.0). The multivariable model showed that unstable housing (aOR: 8.86, 95%CI: 2.68, 29.32) and drug use (aOR: 3.47, 95%CI: 1.33, 9.06) were associated with increased likelihood of HIV testing. However, FSWs with a higher level of income were less likely to be tested for HIV (aOR: 0.09, 95%CI: 0.02, 0.43).
CONCLUSION
Almost one in ten street-based FSWs had never tested for HIV. These findings suggest the need for evidence-based strategies such as outreach support and HIV self-testing to improve HIV testing in this marginalized population.
Identifiants
pubmed: 34001164
doi: 10.1186/s13011-021-00382-x
pii: 10.1186/s13011-021-00382-x
pmc: PMC8130331
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
43Références
PLoS One. 2013 Jun 19;8(6):e66701
pubmed: 23840521
Eur J Contracept Reprod Health Care. 2020 Dec;25(6):434-438
pubmed: 32938240
Sex Transm Infect. 2020 Feb;96(1):68-75
pubmed: 31836679
Int J Drug Policy. 2016 Jun;32:64-9
pubmed: 27157980
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii17-22
pubmed: 23996450
JAMA. 2010 Aug 4;304(5):573-4
pubmed: 20682941
Int J Behav Med. 2017 Aug;24(4):613-618
pubmed: 28124192
Int J Womens Health. 2020 Aug 25;12:681-689
pubmed: 32943942
Eur J Public Health. 2010 Aug;20(4):422-32
pubmed: 20123683
Sex Transm Infect. 2005 Jun;81(3):279-80
pubmed: 15923304
AIDS Behav. 2017 Aug;21(8):2401-2411
pubmed: 28688031
PLoS Med. 2017 Nov 21;14(11):e1002442
pubmed: 29161260
PLoS One. 2016 Jan 25;11(1):e0147587
pubmed: 26807584
Harm Reduct J. 2021 Mar 16;18(1):33
pubmed: 33726756
AIDS Behav. 2018 Aug;22(8):2435-2457
pubmed: 29464430
Addiction. 2013 Jan;108(1):161-70
pubmed: 22775475
Drug Alcohol Depend. 2021 Apr 1;221:108655
pubmed: 33689969
Sex Transm Dis. 2011 Feb;38(2):89-95
pubmed: 20838364
PLoS One. 2017 Aug 10;12(8):e0182755
pubmed: 28796847
Lancet Infect Dis. 2012 Jul;12(7):538-49
pubmed: 22424777
Sex Transm Infect. 2013 Nov;89 Suppl 3:iii37-40
pubmed: 24191292
PLoS Med. 2013 Aug;10(8):e1001496
pubmed: 23966838
Cult Health Sex. 2016;18(1):58-70
pubmed: 26317368
J Int Assoc Provid AIDS Care. 2017 Nov/Dec;16(6):572-578
pubmed: 28974161
AIDS Behav. 2012 Jan;16(1):44-52
pubmed: 21538081
Arch Sex Behav. 2020 Aug;49(6):1923-1937
pubmed: 31701288